CY1351A - Improvements in or relating to 2,4-disubstituted thiazole derivatives - Google Patents

Improvements in or relating to 2,4-disubstituted thiazole derivatives

Info

Publication number
CY1351A
CY1351A CY135181A CY135181A CY1351A CY 1351 A CY1351 A CY 1351A CY 135181 A CY135181 A CY 135181A CY 135181 A CY135181 A CY 135181A CY 1351 A CY1351 A CY 1351A
Authority
CY
Cyprus
Prior art keywords
relating
thiazole derivatives
disubstituted thiazole
disubstituted
derivatives
Prior art date
Application number
CY135181A
Other languages
English (en)
Inventor
Richard Paul Pioch
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22712591&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1351(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of CY1351A publication Critical patent/CY1351A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28—Radicals substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CY135181A 1980-10-02 1981-10-02 Improvements in or relating to 2,4-disubstituted thiazole derivatives CY1351A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/193,192 US4375547A (en) 1980-10-02 1980-10-02 N-Methyl-N'-2-([(2-dimethylaminomethyl)-4-thiazolyl]methylthio)ethyl 2-nitro-1,1-ethenediamine

Publications (1)

Publication Number Publication Date
CY1351A true CY1351A (en) 1987-04-24

Family

ID=22712591

Family Applications (1)

Application Number Title Priority Date Filing Date
CY135181A CY1351A (en) 1980-10-02 1981-10-02 Improvements in or relating to 2,4-disubstituted thiazole derivatives

Country Status (36)

Country Link
US (1) US4375547A (fr)
EP (1) EP0049618B1 (fr)
JP (1) JPS5791980A (fr)
KR (1) KR850001795B1 (fr)
AR (1) AR241439A1 (fr)
AU (1) AU542553B2 (fr)
BG (1) BG60249B2 (fr)
CA (1) CA1166248A (fr)
CS (1) CS227015B2 (fr)
CY (1) CY1351A (fr)
DD (1) DD200371A5 (fr)
DE (1) DE3171819D1 (fr)
DK (2) DK164056C (fr)
EG (1) EG15678A (fr)
ES (2) ES8301950A1 (fr)
FI (2) FI813058L (fr)
GB (1) GB2084581B (fr)
GR (1) GR75023B (fr)
HK (1) HK15987A (fr)
HU (1) HU188697B (fr)
IE (1) IE51603B1 (fr)
IL (1) IL63980A (fr)
LU (1) LU88293I2 (fr)
MX (1) MX5723A (fr)
MY (1) MY8700247A (fr)
NL (1) NL930107I2 (fr)
NO (1) NO155885C (fr)
NZ (1) NZ198523A (fr)
PH (1) PH18135A (fr)
PL (2) PL130526B1 (fr)
PT (1) PT73757B (fr)
RO (2) RO85815B (fr)
SU (1) SU1184443A3 (fr)
UA (1) UA6081A1 (fr)
YU (1) YU42728B (fr)
ZA (1) ZA816817B (fr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4904792A (en) * 1980-10-02 1990-02-27 Eli Lilly And Company N-thiazolymethylthioalkyl-N'-alkylamidines and related compounds
NZ202797A (en) * 1981-12-28 1985-08-30 Lilly Co Eli Pyrimidine derivatives and pharmaceutical compositions
US4474794A (en) * 1982-03-19 1984-10-02 Eli Lilly And Company N-Thiazolylmethylthioalkyl-N1 -alkenyl (or alkynyl)guanidines and related compounds
FR2531703A1 (fr) * 1982-08-13 1984-02-17 Sanofi Sa 2-aza-5-thiahexan-1-ones 1,6-disubstituees, leurs sels, procede pour leur preparation et compositions pharmaceutiques les renfermant
US4587344A (en) * 1983-02-07 1986-05-06 Eli Lilly And Company Isothiourea synthesis process
FI840474A (fi) * 1983-02-07 1984-08-08 Lilly Co Eli Foerbaettringar vid syntes av nizatidin samt foerbaettringar beroerande denna.
US4468517A (en) * 1983-05-12 1984-08-28 Eli Lilly And Company Synthesis of thiazoles
DE3417127A1 (de) * 1984-05-09 1985-11-14 Papst-Motoren GmbH & Co KG, 7742 St Georgen Kleinstventilator
DE3531504A1 (de) * 1985-09-04 1987-03-12 Basf Ag 3-aminomethylpyrrol-1-yl-alkylamine und diese verbindungen enthaltende therapeutische mittel
CA1277325C (fr) * 1985-12-18 1990-12-04 Bruce A. Slomski Synthese de nizatidine
US4777260A (en) * 1985-12-18 1988-10-11 Eli Lilly And Company Synthesis of nizatidine intermediate
EP0285681B1 (fr) * 1987-04-06 1993-03-10 HEUMANN PHARMA GMBH & CO Procédé pour la préparation de dérivés de nitroéthène
ES2007959A6 (es) * 1988-07-11 1989-07-01 Vinas Lab Procedimiento para la obtencion de derivados tiazolicos.
DK0515121T3 (da) * 1991-05-21 2000-11-27 Lilly Co Eli Fremgangsmåde til fremstilling af mellemprodukter for nizatidin og beslægtede forbindelser
ES2038922B1 (es) * 1991-12-30 1994-04-16 Fermentaciones Y Sintesis Espa Procedimiento para la obtencion de nizatidina.
US5294433A (en) * 1992-04-15 1994-03-15 The Procter & Gamble Company Use of H-2 antagonists for treatment of gingivitis
US5574054A (en) * 1992-05-12 1996-11-12 Zeria Pharmaceutical Co., Ltd. Quaternary ammonium salts and use thereof as medicine
US5541335A (en) * 1994-07-11 1996-07-30 Torcan Chemical Ltd. Process for preparing nizatidine
US5470865A (en) * 1994-08-30 1995-11-28 Eli Lilly And Company Pharmaceutical composition
CN1073095C (zh) * 1996-09-11 2001-10-17 克诺尔有限公司 尼扎替丁的制备方法
IT1299198B1 (it) 1998-03-05 2000-02-29 Nicox Sa Sali nitrati di farmaci antiulcera
CA2349575A1 (fr) 1998-11-17 2000-05-25 Nitromed, Inc. Composes et compositions antagonistes de recepteurs de h2 nitroses et nitrosyles et procedes d'utilisation
EP1579862A1 (fr) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Utilisation des inhibiteurs de PDE III pour la réduction de la taille du coeur chez des mammifères souffrant d'insufficances cardiaques
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
EP1750674A4 (fr) * 2004-05-27 2012-05-23 Advanced Bionutrition Corp Microparticules pour administration orale
WO2006071659A1 (fr) * 2004-12-29 2006-07-06 Trustees Of Boston University Delivrance d'antagonistes h2
EP1920785A1 (fr) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Préparation liquide contenant un complexe du pimobendane et de la cyclodextrine
US20090275622A1 (en) * 2008-04-30 2009-11-05 Prasoona Linga Nizatidine formulations
EP3167876B1 (fr) 2012-03-15 2021-09-08 Boehringer Ingelheim Vetmedica GmbH Formulation de comprimé pharmaceutique pour le secteur vétérinaire, son procédé de production et d'utilisation
CN113181110A (zh) 2013-07-19 2021-07-30 勃林格殷格翰动物保健有限公司 含有防腐的醚化的环糊精衍生物的液体水性药物组合物
BR112016011111B1 (pt) 2013-12-04 2022-11-16 Boehringer Ingelheim Vetmedica Gmbh Composições farmacêuticas aprimoradas de pimobendan
EP2929884A1 (fr) 2014-04-11 2015-10-14 Sanovel Ilac Sanayi ve Ticaret A.S. Combinaisons pharmaceutiques de dabigatran et antagonistes du récepteur de h2
EP2942058A1 (fr) 2014-05-09 2015-11-11 Sanovel Ilac Sanayi ve Ticaret A.S. Combinaisons pharmaceutiques de rivaroxaban et des antagonistes du récepteur d'histamine H2
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
EP4196793A1 (fr) 2020-08-11 2023-06-21 Université de Strasbourg Bloqueurs de h2 ciblant des macrophages du foie pour la prévention et le traitement d'une maladie du foie et du cancer

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1338169A (en) * 1971-03-09 1973-11-21 Smith Kline French Lab Ureas thioureas and guanidines
US3917593A (en) * 1972-05-22 1975-11-04 Smithkline Corp N-alkenyl and N-alkynyl (2-quinolyl)thio-acetamides
US3853865A (en) * 1972-06-26 1974-12-10 Smithkline Corp N-aminomethyl-2-amino(and 2-amino-methyl)-2-heterocyclic-thioacetamides
GB1421792A (en) * 1973-05-17 1976-01-21 Smith Kline French Lab Heterocyclic substituted-1, 1-diamino-ethylene derivatives methods for their preparation and compositions containing them
US4191769A (en) * 1974-03-12 1980-03-04 Smith Kline & French Laboratories Limited Isothiourea compounds and pharmacological use
US4061637A (en) * 1974-05-14 1977-12-06 Istituto Luso Farmaco D'italia S.R.L. Certain 4-aryl-5-(4-phenylpiperazino)alkyl-4-thiazolin-2-ones
US4173644A (en) * 1975-02-03 1979-11-06 Smith Kline & French Laboratories Limited Thiourea compounds, compositions and methods and use
US4166856A (en) * 1975-05-21 1979-09-04 Smith Kline & French Laboratories Limited Thiazole and isothiazole derivative as blockers of histamine H2 -receptors
GB1574214A (en) * 1976-03-11 1980-09-03 Smith Kline French Lab Amidines
GB1602458A (en) * 1977-05-05 1981-11-11 Smith Kline French Lab Bisamidines as histamine h2-antagonists
DE2835695A1 (de) * 1977-08-29 1979-03-15 Yamanouchi Pharma Co Ltd Neue heterocyclische verbindungen, verfahren zu ihrer herstellung und arzneimittel, die diese enthalten
JPS5444660A (en) * 1977-08-29 1979-04-09 Yamanouchi Pharmaceut Co Ltd Heterocyclic compound and its preparation
US4210658A (en) * 1977-09-08 1980-07-01 Smith Kline & French Laboratories Limited Amidinosulphonic acid derivatives
DE2905134A1 (de) * 1978-02-17 1979-08-23 Degussa Neue acylierte aminoalkyl-cyanoguanidine mit einem heterocyclischen rest
EP0006679B1 (fr) * 1978-05-24 1982-07-21 Imperial Chemical Industries Plc Dérivés antisécréteurs de thiadiazole, procédé pour leur préparation et compositions pharmaceutiques les contenant
US4200578A (en) * 1978-12-18 1980-04-29 Bristol-Myers Company Thiazole derivatives

Also Published As

Publication number Publication date
IE51603B1 (en) 1987-01-21
AU542553B2 (en) 1985-02-28
KR850001795B1 (ko) 1985-12-21
ZA816817B (en) 1983-05-25
RO82215B (ro) 1983-06-30
US4375547A (en) 1983-03-01
DE3171819D1 (en) 1985-09-19
YU236481A (en) 1983-10-31
BG60249B1 (bg) 1994-03-24
FI813058L (fi) 1982-04-03
IE812285L (en) 1982-04-02
PH18135A (en) 1985-04-03
PL130626B1 (en) 1984-08-31
DK12391D0 (da) 1991-01-24
RO82215A (fr) 1983-07-07
CS227015B2 (en) 1984-04-16
NL930107I2 (nl) 1997-02-03
NO155885B (no) 1987-03-09
SU1184443A3 (ru) 1985-10-07
ES505950A0 (es) 1983-01-01
ES514868A0 (es) 1983-05-01
PT73757A (en) 1981-11-01
PL130526B1 (en) 1984-08-31
LU88293I2 (fr) 1994-05-04
UA6081A1 (uk) 1994-12-29
DK164056B (da) 1992-05-04
DD200371A5 (de) 1983-04-20
EP0049618B1 (fr) 1985-08-14
PL233295A1 (fr) 1982-12-20
HK15987A (en) 1987-02-27
MY8700247A (en) 1987-12-31
AU7594581A (en) 1982-04-08
RO85815B (ro) 1984-11-30
NL930107I1 (nl) 1993-10-18
YU42728B (en) 1988-12-31
JPH021141B2 (fr) 1990-01-10
DK12391A (da) 1991-01-24
DK167759B1 (da) 1993-12-13
GB2084581B (en) 1985-02-27
GR75023B (fr) 1984-07-12
DK435181A (da) 1982-05-12
IL63980A (en) 1986-04-29
CA1166248A (fr) 1984-04-24
ES8301950A1 (es) 1983-01-01
GB2084581A (en) 1982-04-15
DK164056C (da) 1992-09-28
NO813334L (no) 1982-04-05
PL238035A1 (en) 1983-02-28
ES8306135A1 (es) 1983-05-01
FI76570B (fi) 1988-07-29
FI76570C (fi) 1988-11-10
EP0049618A1 (fr) 1982-04-14
RO85815A (fr) 1984-11-25
KR830007602A (ko) 1983-11-04
MX5723A (es) 1993-12-01
IL63980A0 (en) 1982-01-31
EG15678A (en) 1986-12-30
PT73757B (en) 1983-01-13
JPS5791980A (en) 1982-06-08
NZ198523A (en) 1985-12-13
AR241439A1 (es) 1992-07-31
HU188697B (en) 1986-05-28
NO155885C (no) 1987-06-17
BG60249B2 (en) 1994-03-24

Similar Documents

Publication Publication Date Title
DE3171819D1 (en) Improvements in or relating to 2,4-disubstituted thiazole derivatives
GB2035303B (en) 2,3-dicyano-hydroquinone derivatives
CY1315A (en) Improvements in or relating to n-arylbenzamide derivatives
GB2084573B (en) Improvements in or relating to 3-aryl-5-isothiazole derivatives
GB2118556B (en) 26,26,26,27,27,27-hexafluoro-cholesterol derivatives
GB2098620B (en) Improvements in or relating to organic compounds
GB2100760B (en) Improvements in or relating to organic compounds
GB2098203B (en) Novel 4,5-diaryl-thiazole-2-thiol derivatives
GB2017093B (en) 3,3-dichloro-2-azetidinone derivatives
GB2102780B (en) Improvements in or relating to compounds
GB2094301B (en) Improvements in or relating to organic compounds
GB2100303B (en) Improvements in or relating to cardclothing
DE3165175D1 (en) Thiazole derivatives
MY8700516A (en) 17, 18-dehydro-apovincaminol derivatives
KE3680A (en) Improvements in or relating to 2,4-disubstituted thiazole derivatives
GB2109386B (en) Improvements in or relating to organic compounds
ZA825796B (en) 1,2-dithiol-3-ylideneammonium derivatives
GB2104561B (en) Improvements in or relating to organic compounds
GB2101200B (en) Improvements relating to hinges
GB2072677B (en) 1-n-substituted 3',4'-didehydrokanamycin b derivatives
ZA818900B (en) 1,4-disubstituted piperazine derivatives and process for the preparation thereof
GB2013678B (en) 1,4 benzoazine derivatives
GB2112817B (en) Improvements in or relating to organic compounds
GB2093683B (en) Improvements in or relating to garments
GB2075747B (en) Improvements in or relating to thyratrons